Deprecated: $wgMWOAuthSharedUserIDs=false is deprecated, set $wgMWOAuthSharedUserIDs=true, $wgMWOAuthSharedUserSource='local' instead [Called from MediaWiki\HookContainer\HookContainer::run in /var/www/html/w/includes/HookContainer/HookContainer.php at line 135] in /var/www/html/w/includes/Debug/MWDebug.php on line 372
Related Causal Frameworks for Surrogate Outcomes - MaRDI portal

Related Causal Frameworks for Surrogate Outcomes

From MaRDI portal
Publication:3637001

DOI10.1111/j.1541-0420.2008.01106.xzbMath1167.62086OpenAlexW2158228595WikidataQ46286212 ScholiaQ46286212MaRDI QIDQ3637001

Tom Greene, Marshall M. Joffe

Publication date: 30 June 2009

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/j.1541-0420.2008.01106.x




Related Items (30)

Comparing Biomarkers as Principal Surrogate EndpointsEvaluating Correlation-Based Metric for Surrogate Marker Qualification within a Causal Correlation FrameworkOn the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpointsSensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumptionCausal measures of the treatment effect captured by candidate surrogate endpointsProportion of treatment effect mediated by surrogate endpointsRobust Approach to Combining Multiple Markers to Improve SurrogacyTesting for Heterogeneity in the Utility of a Surrogate MarkerEvaluation of longitudinal surrogate markersRejoinderBayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomesBayesian Inference for the Causal Effect of MediationPartially Hidden Markov Model for Time-Varying Principal Stratification in HIV Prevention TrialsA Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical TrialsA causal framework for surrogate endpoints with semi-competing risks dataThe Identification of Direct and Indirect Effects in Studies with an Unmeasured Intermediate VariableStatistical evaluation of surrogate endpoints with examples from cancer clinical trialsBayesian methods for multiple mediators: relating principal stratification and causal mediation in the analysis of power plant emission controlsEquivalence between direct and indirect effects with different sets of intermediate variables and covariatesDiscussion on “Surrogate Measures and Consistent Surrogates”Discussion on “Surrogate Measures and Consistent Surrogates”Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine TrialsAn information-theoretic approach for the evaluation of surrogate endpoints based on causal inferenceA Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference FrameworkAugmented Designs to Assess Principal Strata Direct EffectsEstimation of Direct Effects for Survival Data by using the Aalen Additive Hazards ModelDesign and Estimation for Evaluating Principal Surrogate Markers in Vaccine TrialsEvaluating principal surrogate markers in vaccine trials in the presence of multiphase samplingSurrogate Measures and Consistent SurrogatesExternal validity: from do-calculus to transportability across populations



Cites Work




This page was built for publication: Related Causal Frameworks for Surrogate Outcomes